VEGFA and retinopathy of prematurity: While treatment success may be somewhat influenced by the therapeutic modalities of choice, success is primarily dependent on the timing of intervention, close monitoring, timely re-treatment when indicated, follow-up past NICU discharge, and in cases with persistent ROP and prior anti-VEGF therapy, strong consideration for fluorescein angiography and laser therapy even in the absence of ongoing Type 1 ROP.